Repurposing of MitoTam: Novel Anti-Cancer Drug Candidate Exhibits Potent Activity against Major Protozoan and Fungal Pathogens

Many of the currently available anti-parasitic and anti-fungal frontline drugs have severe limitations, including adverse side effects, complex administration, and increasing occurrence of resistance. The discovery and development of new therapeutic agents is a costly and lengthy process. Therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales: Arbon, Dominik, Ženíšková, Kateřina, Šubrtová, Karolína, Mach, Jan, Štursa, Jan, Machado, Marta, Zahedifard, Farnaz, Leštinová, Tereza, Hierro-Yap, Carolina, Neuzil, Jiri, Volf, Petr, Ganter, Markus, Zoltner, Martin, Zíková, Alena, Werner, Lukáš, Sutak, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380531/
https://www.ncbi.nlm.nih.gov/pubmed/35856666
http://dx.doi.org/10.1128/aac.00727-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380531/
https://www.ncbi.nlm.nih.gov/pubmed/35856666
http://dx.doi.org/10.1128/aac.00727-22

Ejemplares similares